英文簡介Middle East Journal Of Cancer期刊介紹

The Middle East Journal of Cancer (MEJC) is an internationally peer-reviewed journal dedicated to publishing high-quality basic science and clinical research papers. This magazine covers a wide range of fields in cancer research, including cancer cell biology, cancer genetics, tumor virology, tumor immunology, cancer treatment, as well as epidemiology and cancer prevention. MEJC aims to promote the progress of cancer research in the Middle East and even globally, and provide a platform for researchers to publish and exchange the latest research results.

Its characteristic lies in its comprehensive coverage of cancer research, especially in the Middle East region. This journal emphasizes the publication of research that can arouse interdisciplinary interest and encourages the submission of technically solid and experimentally detailed papers. MEJC's academic positioning is to become one of the authoritative journals in the field of cancer research, providing high impact research results for scientists and medical professionals worldwide. In addition, it is of great significance to the cancer research community, as it not only provides a platform for publishing research, but also helps to promote the translation of scientific discoveries into clinical practice. By publishing research from different regions, MEJC has promoted collaboration and knowledge sharing in global cancer research, which has had a positive impact on improving global cancer management.

期刊簡介Middle East Journal Of Cancer期刊介紹

《Middle East Journal Of Cancer》該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

• 預計審稿時間： 12 Weeks
• SCIE
• 非預警